Sympazan Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
2
Sympazan General Information
Description
Manufacturer of oral film intended for patients aged two years of age or older. The company offers opioid medicines, alcohol, and other central nervous system (CNS) depressants (including street drugs) that can be taken without water or liquid, adhere to the tongue, and dissolve to deliver clobazam.
Contact Information
Website
www.sympazan.com(Operating Subsidiary)
Corporate Office
- Warren, NJ
- United States
Corporate Office
- Warren, NJ
- United States
Sympazan Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sympazan Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Sympazan FAQs
-
Where is Sympazan headquartered?
Sympazan is headquartered in Warren, NJ.
-
What industry is Sympazan in?
Sympazan’s primary industry is Pharmaceuticals.
-
Is Sympazan a private or public company?
Sympazan is a Private company.
-
What is Sympazan’s current revenue?
The current revenue for Sympazan is .
-
Who are Sympazan’s investors?
Aquestive Therapeutics and Assertio Holdings have invested in Sympazan.
-
When was Sympazan acquired?
Sympazan was acquired on 08-Apr-2026.
-
Who acquired Sympazan?
Sympazan was acquired by Cosette Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process